Ellis Investment Partners’s Bio-Techne TECH Stock Holding History

Ellis Investment Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,416	Closed	-$200K	–	216
2022 Q4	$200K	Hold	2,416	–	–	0.05%	199
2022 Q3	$171K	Hold	2,416	–	–	0.05%	211
2022 Q2	$209K	Hold	2,416	–	–	0.06%	190
2022 Q1	$261K	Hold	2,416	–	–	0.06%	181
2021 Q4	$312K	Hold	2,416	–	–	0.07%	174
2021 Q3	$292K	Hold	2,416	–	–	0.07%	169
2021 Q2	$271K	Hold	2,416	–	–	0.07%	170
2021 Q1	$231K	Hold	2,416	–	–	0.06%	183
2020 Q4	$192K	Hold	2,416	–	–	0.06%	190
2020 Q3	$149K	Hold	2,416	–	–	0.05%	208
2020 Q2	$160K	Hold	2,416	–	–	0.06%	184
2020 Q1	$111K	Hold	2,416	–	–	0.05%	178
2019 Q4	$132K	Hold	2,416	–	–	0.04%	197
2019 Q3	$114K	Hold	2,416	–	–	0.04%	210
2019 Q2	$126K	Buy	+2,416	New	+$122K	0.05%	194

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ellis Investment Partners's TECH Position: Q1 2023 in Review

Ellis Investment Partners sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 2,416 shares — an estimated $200K sold.

Ellis Investment Partners first reported a position in TECH in Q2 2019 and held it in 15 quarters. The position peaked at $312K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

Ellis Investment Partners reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
Ellis Investment Partners sold 2,416 Bio-Techne shares in Q1 2023, an estimated $200K.
Ellis Investment Partners first reported a position in Bio-Techne in Q2 2019 and held it in 15 quarters.
Ellis Investment Partners's Bio-Techne position peaked at $312K in Q4 2021.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Ellis Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.